The epithelium in idiopathic pulmonary fibrosis: Breaking the barrier

Frontiers in Pharmacology

Volumn 4 JAN, Issue , 2014, Pages

  Camelo, Ana ^a   Dunmore, Rebecca ^a   Sleeman, Matthew A ^a   Clarke, Deborah L ^a  

^a MEDIMMUNE   (United States)

Author keywords

Apoptosis; Epithelium; Fibroblasts; Idiopathic pulmonary fibrosis; TGF

Indexed keywords

CHEMOKINE; INTEGRIN; TRANSFORMING GROWTH FACTOR BETA;

CELL ACTIVATION; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; EFFECTOR CELL; EPITHELIUM CELL; FIBROSING ALVEOLITIS; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; MOLECULAR PATHOLOGY; MYOFIBROBLAST; NONHUMAN; OUTCOME ASSESSMENT; PERMEABILITY BARRIER; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84893797280     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00173     Document Type: Review

References (107)

1. Adamali, H. I., and Maher, T. M. (2012). Current and novel drug therapies for idiopathic pulmonary fibrosis. Drug Des. Dev. Ther. 6, 261-272. doi: 10.2147/DDDT.S29928.
2. Agostini, C., and Gurrieri, C. (2006). Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc. Am. Thorac. Soc. 3, 357-363. doi: 10.1513/pats.200601-010TK.
3. Andersson-Sjoland, A., de Alba, C. G., Nihlberg, K., Becerril, C., Ramirez, R., Pardo, A., et al. (2008). Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int. J. Biochem. Cell Biol. 40, 2129-2140. doi: 10.1016/j.biocel.2008.02.012.
4. Annes, J. P., Munger, J. S., and Rifkin, D. B. (2003). Making sense of latent TGFbeta activation. J Cell Sci. 116(Pt 2), 217-224. doi: 10.1242/jcs.00229.
5. Antoniou, K. M., Papadaki, H. A., Soufla, G., Kastrinaki, M. C., Damianaki, A., Koutala, H., et al. (2010). Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in idiopathic pulmonary fibrosis (IPF). Respir. Med. 104, 1535-1542. doi: 10.1016/j.rmed.2010.04.015.
6. Antoniou, K. M., Tzanakis, N., Tzortzaki, E. G., Malagari, K., Koutsopoulos, A. V., Alexandrakis, M., et al. (2008). Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients. Pulm. Pharmacol. Ther. 21, 840-844. doi: 10.1016/j.pupt.2008.06.005.
7. Asano, Y., Ihn, H., Yamane, K., Jinnin, M., Mimura, Y., and Tamaki, K. (2005). Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. J. Immunol. 175, 7708-7718.
8. Besnard, A. G., Struyf, S., Guabiraba, R., Fauconnier, L., Rouxel, N., Proost, P., et al. (2013). CXCL6 antibody neutralization prevents lung inflammation and fibrosis in mice in the bleomycin model. J. Leukoc. Biol. 94, 1317-1323. doi: 10.1189/jlb.0313140.
9. Bonniaud, P., Margetts, P. J., Kolb, M., Schroeder, J. A., Kapoun, A. M., Damm, D., et al. (2005). Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am. J. Respir. Crit. Care Med. 171, 889-898. doi: 10.1164/rccm.200405-612OC.
10. Borowski, A., Kuepper, M., Horn, U., Knupfer, U., Zissel, G., Hohne, K., et al. (2008). Interleukin-13 acts as an apoptotic effector on lung epithelial cells and induces pro-fibrotic gene expression in lung fibroblasts. Clin. Exp. Allergy 38, 619-628. doi: 10.1111/j.1365-2222.2008.02944.x.
11. Cardoso, W. V., and Whitsett, J. A. (2008). Resident cellular components of the lung: developmental aspects. Proc. Am. Thorac. Soc. 5, 767-771. doi: 10.1513/pats.200803-026HR.
12. Chambers, R. C. (2008). Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? Br. J. Pharmacol. 153(Suppl. 1), S367-S378. doi: 10.1038/sj.bjp.0707603.
13. Chandler, D. B. (1990). Possible mechanisms of bleomycin-induced fibrosis. Clin. Chest Med. 11, 21-30.
14. Chapman, H. A. (2011). Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu. Rev. Physiol. 73, 413-435. doi: 10.1146/annurev-physiol-012110-142225.
15. Chen, R., Lim, J. H., Jono, H., Gu, X. X., Kim, Y. S., Basbaum, C. B., et al. (2004). Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKbeta-IkappaBalpha-NF-kappaB signaling pathways. Biochem. Biophys. Res. Commun. 324, 1087-1094. doi: 10.1016/j.bbrc.2004.09.157.
16. Chilosi, M., Carloni, A., Rossi, A., and Poletti, V. (2013). Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema. Transl. Res. 162, 156-173. doi: 10.1016/j.trsl.2013.06.004.
17. Chilosi, M., Poletti, V., and Rossi, A. (2012). The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir. Res. 13, 3. doi: 10.1186/1465-9921-13-3.
18. Coker, R. K., Laurent, G. J., Jeffery, P. K., du Bois, R. M., Black, C. M., and McAnulty, R. J. (2001). Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung. Thorax 56, 549-556. doi: 10.1136/thorax.56.7.549.
19. Cui, A., Anhenn, O., Theegarten, D., Ohshimo, S., Bonella, F., Sixt, S. U., et al. (2001). Angiogenic and angiostatic chemokines in idiopathic pulmonary fibrosis and granulomatous lung disease. Respiration 80, 372-378. doi: 10.1159/000245332.
20. Daniels, C. E., Wilkes, M. C., Edens, M., Kottom, T. J., Murphy, S. J., Limper, A. H., et al. (2004). Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J. Clin. Invest. 114, 1308-1316.
21. Davidovich, N., DiPaolo, B. C., Lawrence, G. G., Chhour, P., Yehya, N., and Margulies, S. S. (2013). Cyclic stretch-induced oxidative stress increases pulmonary alveolar epithelial permeability. Am. J. Respir. Cell Mol. Biol. 49, 156-164. doi: 10.1165/rcmb.2012-0252OC.
22. Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., et al. (2005). Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115, 56-65.
23. Fahim, A., Chong, M. C., Crooks, M. G., and Hart, S. P. (2012). Idiopathic pulmonary fibrosis is associated with circulating antiepithelial antibodies. Lung 190, 451-458. doi: 10.1007/s00408-012-9390-z.
24. Fahy, J. V., and Dickey, B. F. (2010). Airway mucus function and dysfunction. N. Engl. J. Med. 363, 2233-2247. doi: 10.1056/NEJMra0910061.
25. Fingerlin, T. E., Murphy, E., Zhang, W., Peljto, A. L., Brown, K. K., Steele, M. P., et al. (2013). Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat. Genet. 45, 613-620. doi: 10.1038/ng.2609.
26. Gerard, C., and Rollins, B. J. (2001). Chemokines and disease. Nat. Immunol. 2, 108-115. doi: 10.1038/84209.
27. Ghosh, M. C., Gorantla, V., Makena, P. S., Luellen, C., Sinclair, S. E., Schwingshackl, A., et al. (2013). Insulin-like growth factor-I stimulates differentiation of ATII cells to ATI-like cells through activation of Wnt5a. Am. J. Physiol. Lung Cell. Mol. Physiol. 305, L222-L228. doi: 10.1152/ajplung.00014.2013.
28. Giacomini, M. M., Travis, M. A., Kudo, M., and Sheppard, D. (2012). Epithelial cells utilize cortical actin/myosin to activate latent TGF-beta through integrin alpha(v)beta(6)-dependent physical force. Exp. Cell Res. 318, 716-722. doi: 10.1016/j.yexcr.2012.01.020.
29. Gras, D., Chanez, P., Vachier, I., Petit, A., and Bourdin, A. (2013). Bronchial epithelium as a target for innovative treatments in asthma. Pharmacol. Ther. 140, 290-305. doi: 10.1016/j.pharmthera.2013.07.008.
30. Guarino, M., Tosoni, A., and Nebuloni, M. (2009). Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Hum. Pathol. 40, 1365-1376. doi: 10.1016/j.humpath.2009.02.020.
31. Hauber, H. P., Foley, S. C., and Hamid, Q. (2006). Mucin overproduction in chronic inflammatory lung disease. Can. Respir. J. 13, 327-335.
32. Hong, K. U., Reynolds, S. D., Watkins, S., Fuchs, E., and Stripp, B. R. (2004). Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am. J. Pathol. 164, 577-588. doi: 10.1016/S0002-9440(10)63147-1.
33. Hoyt, R. F. Jr., McNelly, N. A., McDowell, E. M., and Sorokin, S. P. (1991). Neuroepithelial bodies stimulate proliferation of airway epithelium in fetal hamster lung. Am. J. Physiol. 260(Pt 1), L234-L240.
34. Hu, Y., Peng, J., Feng, D., Chu, L., Li, X., Jin, Z., et al. (2006). Role of extracellular signal-regulated kinase, p38 kinase, and activator protein-1 in transforming growth factor-beta1-induced alpha smooth muscle actin expression in human fetal lung fibroblasts in vitro. Lung 184, 33-42. doi: 10.1007/s00408-005-2560-5.
35. Hunninghake, G. M., Hatabu, H., Okajima, Y., Gao, W., Dupuis, J., Latourelle, J. C., et al. (2013). MUC5B promoter polymorphism and interstitial lung abnormalities. N. Engl. J. Med. 368, 2192-2200. doi: 10.1056/NEJMoa1216076.
36. Jenkins, G. (2008). The role of proteases in transforming growth factor-beta activation. Int. J. Biochem. Cell Biol. 40, 1068-1078. doi: 10.1016/j.biocel.2007.11.026.
37. Jenkins, R. G., Su, X., Su, G., Scotton, C. J., Camerer, E., Laurent, G. J., et al. (2006). Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J. Clin. Invest. 116, 1606-1614. doi: 10.1172/JCI27183.
38. Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., et al. (2005). Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11, 1173-1179. doi: 10.1038/nm1315.
39. Jin, H. L., and Dong, J. C. (2011). Pathogenesis of idiopathic pulmonary fibrosis: from initial apoptosis of epithelial cells to lung remodeling? Chin. Med. J. 124, 4330-4338.
40. Kinder, B. W., Brown, K. K., Schwarz, M. I., Ix, J. H., Kervitsky, A., and King, T. E. Jr. (2008). Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest 133, 226-232. doi: 10.1378/chest.07-1948.
41. King, T. E. Jr., Pardo, A., and Selman, M. (2011). Idiopathic pulmonary fibrosis. Lancet 378, 1949-1961. doi: 10.1016/S0140-6736(11)60052-4.
42. Kotsianidis, I., Nakou, E., Bouchliou, I., Tzouvelekis, A., Spanoudakis, E., Steiropoulos, P., et al. (2009). Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 179, 1121-1130. doi: 10.1164/rccm.200812-1936OC.
43. Kuwano, K., Hagimoto, N., Kawasaki, M., Yatomi, T., Nakamura, N., Nagata, S., et al. (1999). Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J. Clin. Invest. 104, 13-19. doi: 10.1172/JCI5628.
44. Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., et al. (2001). Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J. Exp. Med. 194, 809-821. doi: 10.1084/jem.194.6.809.
45. Lee, J. S., Song, J. W., Wolters, P. J., Elicker, B. M., King, T. E. Jr., Kim, D. S., et al. (2012). Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis. Eur. Respir. J. 39, 352-358. doi: 10.1183/09031936.00050911.
46. LeVine, A. M., and Whitsett, J. A. (2001). Pulmonary collectins and innate host defense of the lung. Microbes Infect. 3, 161-166. doi: 10.1016/S1286-4579(00)01363-0.
47. Li, J. D., Dohrman, A. F., Gallup, M., Miyata, S., Gum, J. R., Kim, Y. S., et al. (1997). Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Proc. Natl. Acad. Sci. U.S.A. 94, 967-972. doi: 10.1073/pnas.94.3.967.
48. Li, M., Krishnaveni, M. S., Li, C., Zhou, B., Xing, Y., Banfalvi, A., et al. (2011). Epithelium-specific deletion of TGF-beta receptor type II protects mice from bleomycin-induced pulmonary fibrosis. J. Clin. Invest. 121, 277-287. doi: 10.1172/JCI42090.
49. Liu, F., Liu, J., Weng, D., Chen, Y., Song, L., He, Q., et al. (2010). CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice. PLoS ONE 5:e15404. doi: 10.1371/journal.pone.0015404.
50. Marchal-Somme, J., Uzunhan, Y., Marchand-Adam, S., Valeyre, D., Soumelis, V., Crestani, B., et al. (2006). Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J. Immunol. 176, 5735-5739.
51. Margaritopoulos, G. A., Antoniou, K. M., Karagiannis, K., Samara, K. D., Lasithiotaki, I., Vassalou, E., et al. (2010). Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study. Fibrogenesis Tissue Repair 3, 20. doi: 10.1186/1755-1536-3-20.
52. Margaritopoulos, G. A., Giannarakis, I., Siafakas, N. M., and Antoniou, K. M. (2013). An update on idiopathic pulmonary fibrosis. Panminerva Med. 55, 109-120.
53. McHedlidze, T., Waldner, M., Zopf, S., Walker, J., Rankin, A. L., Schuchmann, M., et al. (2013). Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity 39, 357-371. doi: 10.1016/j.immuni.2013.07.018.
54. McKee, C. M., Penno, M. B., Cowman, M., Burdick, M. D., Strieter, R. M., Bao, C., et al. (1996). Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J. Clin. Invest. 98, 2403-2413. doi: 10.1172/JCI119054.
55. Mercer, P. F., Johns, R. H., Scotton, C. J., Krupiczojc, M. A., Konigshoff, M., Howell, D. C., et al. (2009). Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 179, 414-425. doi: 10.1164/rccm.200712-1827OC.
56. Millien, V. O., Lu, W., Shaw, J., Yuan, X., Mak, G., Roberts, L., et al. (2013). Cleavage of fibrinogen by proteinases elicits allergic responses through Toll-like receptor 4. Science 341, 792-796. doi: 10.1126/science.1240342.
57. Moustakas, A., and Heldin, C. H. (2009). The regulation of TGFbeta signal transduction. Development 136, 3699-3714. doi: 10.1242/dev.030338.
58. Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J., Dalton, S. L., Wu, J., et al. (1999). The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319-328. doi: 10.1016/S0092-8674(00)80545-0.
59. Murray, L. A., Argentieri, R. L., Farrell, F. X., Bracht, M., Sheng, H., Whitaker, B., et al. (2008). Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2. Int. J. Biochem. Cell Biol. 40, 2174-2182. doi: 10.1016/j.biocel.2008.02.016.
60. Nicholas, B., Skipp, P., Mould, R., Rennard, S., Davies, D. E., O'Connor, C. D., et al. (2006). Shotgun proteomic analysis of human-induced sputum. Proteomics 6, 4390-4401. doi: 10.1002/pmic.200600011.
61. Nishimura, S. L. (2009). Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders. Am. J. Pathol. 175, 1362-1370. doi: 10.2353/ajpath.2009.090393.
62. Noble, P. W., Barkauskas, C. E., and Jiang, D. (2012). Pulmonary fibrosis: patterns and perpetrators. J. Clin. Invest. 122, 2756-2762. doi: 10.1172/JCI60323.
63. O'Dwyer, D. N., Armstrong, M. E., Trujillo, G., Cooke, G., Keane, M. P., Fallon, P. G., et al. (2013). The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 188, 1442-1450.
64. Pardo, A., Barrios, R., Gaxiola, M., Segura-Valdez, L., Carrillo, G., Estrada, A., et al. (2000). Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. Am. J. Respir. Crit. Care Med. 161, 1698-1704. doi: 10.1164/ajrccm.161.5.9907065.
65. Paun, A., Fox, J., Balloy, V., Chignard, M., Qureshi, S. T., and Haston, C. K. (2010). Combined Tlr2 and Tlr4 deficiency increases radiation-induced pulmonary fibrosis in mice. Int. J. Radiat. Oncol. Biol. Phys. 77, 1198-1205. doi: 10.1016/j.ijrobp.2009.12.065.
66. Peljto, A. L., Zhang, Y., Fingerlin, T. E., Ma, S. F., Garcia, J. G., Richards, T. J., et al. (2013). Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA 309, 2232-2239. doi: 10.1001/jama.2013.5827.
67. Perng, D. W., Chang, K. T., Su, K. C., Wu, Y. C., Wu, M. T., Hsu, W. H., et al. (2007). Exposure of airway epithelium to bile acids associated with gastroesophageal reflux symptoms: a relation to transforming growth factor-beta1 production and fibroblast proliferation. Chest 132, 1548-1556. doi: 10.1378/chest.07-1373.
68. Plataki, M., Koutsopoulos, A. V., Darivianaki, K., Delides, G., Siafakas, N. M., and Bouros, D. (2005). Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest 127, 266-274. doi: 10.1378/chest.127.1.266.
69. Prasse, A., and Muller-Quernheim, J. (2009). Non-invasive biomarkers in pulmonary fibrosis. Respirology 14, 788-795. doi: 10.1111/j.1440-1843.2009.01600.x.
70. Psathakis, K., Mermigkis, D., Papatheodorou, G., Loukides, S., Panagou, P., Polychronopoulos, V., et al. (2006). Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. Eur. J. Clin. Invest. 36, 362-367. doi: 10.1111/j.1365-2362.2006.01636.x.
71. Rackley, C. R., and Stripp, B. R. (2012). Building and maintaining the epithelium of the lung. J. Clin. Invest. 122, 2724-2730. doi: 10.1172/JCI60519.
72. Razonable, R. R., Henault, M., and Paya, C. V. (2006). Stimulation of Toll-like receptor 2 with bleomycin results in cellular activation and secretion of pro-inflammatory cytokines and chemokines. Toxicol. Appl. Pharmacol. 210, 181-189. doi: 10.1016/j.taap.2005.05.002.
73. Richards, T. J., Kaminski, N., Baribaud, F., Flavin, S., Brodmerkel, C., Horowitz, D., et al. (2012). Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 185, 67-76. doi: 10.1164/rccm.201101-0058OC.
74. Roche, W. R., Montefort, S., Baker, J., and Holgate, S. T. (1993). Cell adhesion molecules and the bronchial epithelium. Am. Rev. Respir. Dis. 148(Pt 2), S79-S82. doi: 10.1164/ajrccm/148.6_Pt_2.S79.
75. Rogers, D. F. (2004). Airway mucus hypersecretion in asthma: an undervalued pathology? Curr. Opin. Pharmacol. 4, 241-250. doi: 10.1016/j.coph.2004.01.011.
76. Rojas, M., Xu, J., Woods, C. R., Mora, A. L., Spears, W., Roman, J., et al. (2005). Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am. J. Respir. Cell Mol. Biol. 33, 145-152. doi: 10.1165/rcmb.2004-0330OC.
77. Rose, M. C., Nickola, T. J., and Voynow, J. A. (2001). Airway mucus obstruction: mucin glycoproteins, MUC gene regulation and goblet cell hyperplasia. Am. J. Respir. Cell Mol. Biol. 25, 533-537. doi: 10.1165/ajrcmb.25.5.f218.
78. Sakai, N., and Tager, A. M. (2013). Fibrosis of two: epithelial cell-fibroblast interactions in pulmonary fibrosis. Biochim. Biophys. Acta 1832, 911-921. doi: 10.1016/j.bbadis.2013.03.001.
79. Samara, K. D., Antoniou, K. M., Karagiannis, K., Margaritopoulos, G., Lasithiotaki, I., Koutala, E., et al. (2012). Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis. Int. J. Oncol. 40, 1397-1404. doi: 10.3892/ijo.2012.1374.
80. Santibanez, J. F., Quintanilla, M., and Bernabeu, C. (2011). TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions. Clin. Sci. 121, 233-251. doi: 10.1042/CS20110086.
81. Savla, U., and Waters, C. M. (1998). Mechanical strain inhibits repair of airway epithelium in vitro. Am. J. Physiol. 274(Pt 1), L883-L892.
82. Scaffidi, P., Misteli, T., and Bianchi, M. E. (2002). Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195. doi: 10.1038/nature00858.
83. Scheibner, K. A., Lutz, M. A., Boodoo, S., Fenton, M. J., Powell, J. D., and Horton, M. R. (2006). Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177, 1272-1281.
84. Seibold, M. A., Wise, A. L., Speer, M. C., Steele, M. P., Brown, K. K., Loyd, J. E., et al. (2011). A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 364, 1503-1512. doi: 10.1056/NEJMoa1013660.
85. Selman, M., and Pardo, A. (2006). Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc. Am. Thorac. Soc. 3, 364-372. doi: 10.1513/pats.200601-003TK.
86. Serrano-Mollar, A. (2012). Alveolar epithelial cell injury as an etiopathogenic factor in pulmonary fibrosis. Arch. Bronconeumol. 48(Suppl. 2), 2-6. doi: 10.1016/S0300-2896(12)70044-3.
87. Sheppard, D. (2006). Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc. Am. Thorac. Soc. 3, 413-417. doi: 10.1513/pats.200601-008AW.
88. Solovyan, V. T., and Keski-Oja, J. (2006). Proteolytic activation of latent TGF-beta precedes caspase-3 activation and enhances apoptotic death of lung epithelial cells. J. Cell. Physiol. 207, 445-453. doi: 10.1002/jcp.20607.
89. Sterclova, M., Vasakova, M., Pavlicek, J., Metlicka, M., Krasna, E., and Striz, I. (2009). Chemokine receptors in a regulation of interstitial lung fibrosis and inflammation. Exp. Lung Res. 35, 514-523. doi: 10.1080/01902140902759282.
90. Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., et al. (1995). The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270, 27348-27357. doi: 10.1074/jbc.270.45.27348.
91. Strieter, R. M., Starko, K. M., Enelow, R. I., Noth, I., and Valentine, V. G. (2004). Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 170, 133-140. doi: 10.1164/rccm.200312-1670OC.
92. Sullivan, D. E., Ferris, M., Pociask, D., and Brody, A. R. (2008). The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo. J. Immunotoxicol. 5, 145-149. doi: 10.1080/15476910802085822.
93. Taille, C., Grootenboer-Mignot, S., Boursier, C., Michel, L., Debray, M. P., Fagart, J., et al. (2011). Identification of periplakin as a new target for autoreactivity in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 183, 759-766. doi: 10.1164/rccm.201001-0076OC.
94. Tatler, A. L., and Jenkins, G. (2012). TGF-beta activation and lung fibrosis. Proc. Am. Thorac. Soc. 9, 130-136. doi: 10.1513/pats.201201-003AW.
95. The Idiopathic Pulmonary Fibrosis Clinical Research Network. (2012). Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N. Engl. J. Med. 366, 1968-1977. doi: 10.1056/NEJMoa1113354.
96. Thomas, A. Q., Lane, K., Phillips, J. III, Prince, M., Markin, C., Speer, M., et al. (2002). Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am. J. Respir. Crit. Care Med. 165, 1322-1328. doi: 10.1164/rccm.200112-123OC.
97. Tsuji, T., Aoshiba, K., and Nagai, A. (2004). Cigarette smoke induces senescence in alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 31, 643-649. doi: 10.1165/rcmb.2003-0290OC.
98. Tsukamoto, K., Hayakawa, H., Sato, A., Chida, K., Nakamura, H., and Miura, K. (2000). Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. Thorax 55, 958-961. doi: 10.1136/thorax.55.11.958.
99. Vareille, M., Kieninger, E., Edwards, M. R., and Regamey, N. (2011). The airway epithelium: soldier in the fight against respiratory viruses. Clin. Microbiol. Rev. 24, 210-229. doi: 10.1128/CMR.00014-10.
100. Waghray, M., Cui, Z., Horowitz, J. C., Subramanian, I. M., Martinez, F. J., Toews, G. B., et al. (2005). Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts. FASEB J. 19, 854-856.
101. Willis, B. C., duBois, R. M., and Borok, Z. (2006). Epithelial origin of myofibroblasts during fibrosis in the lung. Proc. Am. Thorac. Soc. 3, 377-3782. doi: 10.1513/pats.200601-004TK.
102. Wilson, M. S., and Wynn, T. A. (2009). Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2, 103-121. doi: 10.1038/mi.2008.85.
103. Wynn, T. A. (2011). Integrating mechanisms of pulmonary fibrosis. J. Exp. Med. 208, 1339-1350. doi: 10.1084/jem.20110551.
104. Wynn, T. A., and Ramalingam, T. R. (2012). Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18, 1028-1040. doi: 10.1038/nm.2807.
105. Xu, J., Gonzalez, E. T., Iyer, S. S., Mac, V., Mora, A. L., Sutliff, R. L., et al. (2009). Use of senescence-accelerated mouse model in bleomycin-induced lung injury suggests that bone marrow-derived cells can alter the outcome of lung injury in aged mice. J. Gerontol. A Biol. Sci. Med. Sci. 64, 731-739. doi: 10.1093/gerona/glp040.
106. Yang, H. Z., Cui, B., Liu, H. Z., Chen, Z. R., Yan, H. M., Hua, F., et al. (2009). Targeting TLR2 attenuates pulmonary inflammation and fibrosis by reversion of suppressive immune microenvironment. J. Immunol. 182, 692-702.
107. Yang, I. V., Coldren, C. D., Leach, S. M., Seibold, M. A., Murphy, E., Lin, J., et al. (2013). Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis. Thorax 68, 1114-1121. doi: 10.1136/thoraxjnl-2012-202943.